Recombinant Anti-CD19 Antibody (V3S-0622-YC2959) (CAT#: V3S-0622-YC2959)

Send Inquiry
  • fig1
    Figure 1 Anti-CD19 Monoclonal Antibody (V3S-0622-YC2959) in ELISA
  • fig1
    Figure 2 Anti-CD19 Monoclonal Antibody (V3S-0622-YC2959) in WB

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a human monoclonal antibody that reacts with CD19. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation.
Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free.
Clonality Monoclonal
Host Species Human
Target Species Human
Isotype IgG

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and/or SEC-HPLC
Endotoxin <1 EU/mg, determined by LAL method
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C.

Applications

Application ELISA; WB
Application Notes The antibody is recommended for detection of CD19 by ELISA, WB assays.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target CD19
Alternative Name CD19 Molecule; B-Lymphocyte Surface Antigen B4; T-Cell Surface Antigen Leu-12; Differentiation Antigen CD19; CD19 Antigen; B-Lymphocyte Antigen CD19; CVID3; B4;
Gene ID 930
UniProt P15391
Research Area Immunology; Stem Cell

Tested Data

ELISA

Figure 1 Anti-CD19 Monoclonal Antibody (V3S-0622-YC2959) in ELISA

ELISA analysis of V3S-0622-YC2959 was performed by coating with Recombinant Human CD19 Protein. Then blocked with BSA, and incubated with Anti-Human CD19 Antibody (V3S-0622-YC2959). The HRP-conjugated anti-human IgG as a secondary antibody. Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.

Figure 1 Anti-CD19 Monoclonal Antibody (V3S-0622-YC2959) in ELISA

WB

Figure 2 Anti-CD19 Monoclonal Antibody (V3S-0622-YC2959) in WB

Western blot analysis of V3S-0622-YC2959 was performed by loading Recombinant Human CD19 Protein onto a 12% Tris-HCl polyacrylamide gel. Proteins were transferred to a CN membrane and blocked with 5% skim milk for at least one hour. Membranes were probed with V3S-0622-YC2959 and HRP Anti-Human IgG as a secondary antibody. Chemiluminescent detection was performed.
Lane 1: Reducing antigen (0.1 μg)
Lane 2: Reducing antigen (0.2 μg)
Lane 3: Reducing antigen (0.3 μg)

Figure 2 Anti-CD19 Monoclonal Antibody (V3S-0622-YC2959) in WB

For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry